Webinar Q&A: RSV – slide set
Since 2023, the Joint Committee on Vaccination and Immunisation (JCVI) has been actively reviewing evidence and considering a range of issues including disease epidemiology, vaccine efficacy, vaccine safety and the cost-effectiveness of introducing a routine RSV vaccination programme in the UK.